2024 |
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression |
Articolo in rivista |
Vai |
2024 |
Lipid droplets and small extracellular vesicles: More than two independent entities |
Articolo in rivista |
Vai |
2024 |
Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory |
Articolo in rivista |
Vai |
2023 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells |
Articolo in rivista |
Vai |
2023 |
Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation |
Articolo in rivista |
Vai |
2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Vai |
2022 |
Targeting epigenetic alterations in cancer stem cells |
Review essay (rassegna critica) |
Vai |
2022 |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
2022 |
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 |
Articolo in rivista |
Vai |
2022 |
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy |
Review essay (rassegna critica) |
Vai |
2022 |
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy |
Review essay (rassegna critica) |
Vai |
2022 |
Cancer cell targeting by CAR-T cells: A matter of stemness |
Review essay (rassegna critica) |
Vai |
2021 |
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome |
Articolo in rivista |
Vai |
2021 |
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment |
Review essay (rassegna critica) |
Vai |
2021 |
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs |
Articolo in rivista |
Vai |
2021 |
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy |
Articolo in rivista |
Vai |
2021 |
Targeting Phosphatases and Kinases: How to Checkmate Cancer |
Articolo in rivista |
Vai |
2021 |
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery |
Articolo in rivista |
Vai |
2021 |
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells |
Articolo in rivista |
Vai |
2021 |
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin |
Articolo in rivista |
Vai |
2021 |
Magnetic Nanoparticle-Based Hyperthermia Mediates Drug Delivery and Impairs the Tumorigenic Capacity of Quiescent Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
2020 |
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities |
Review essay (rassegna critica) |
Vai |
2020 |
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant |
Articolo in rivista |
Vai |
2020 |
ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
2020 |
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis |
Articolo in rivista |
Vai |
2019 |
Correction to: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 (Cell Death & Differentiation, (2008), 15, 4, (762-772), 10.1038/sj.cdd.4402305) |
Nota o commento |
Vai |
2019 |
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway |
Articolo in rivista |
Vai |
2019 |
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy |
Articolo in rivista |
Vai |
2019 |
Cancer Stem Cells: From Birth to Death |
Capitolo o Saggio |
Vai |
2019 |
Meeting the Challenge of Targeting Cancer Stem Cells |
Articolo in rivista |
Vai |
2018 |
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells |
Articolo in rivista |
Vai |
2018 |
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells |
Articolo in rivista |
Vai |
2018 |
Capturing Colorectal Cancer Inter-Tumor Heterogeneity in Patient-Derived Xenograft (PDX) Models |
Articolo in rivista |
Vai |
2018 |
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state |
Articolo in rivista |
Vai |
2017 |
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage |
Articolo in rivista |
Vai |
2017 |
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma |
Articolo in rivista |
Vai |
2017 |
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer |
Articolo in rivista |
Vai |
2017 |
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer |
Articolo in rivista |
Vai |
2017 |
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells |
Recensione in rivista |
Vai |
2017 |
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer |
Articolo in rivista |
Vai |
2017 |
Role of Type I and II interferons in colorectal cancer and melanoma |
Recensione in rivista |
Vai |
2017 |
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition |
Articolo in rivista |
Vai |
2016 |
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. |
Articolo in rivista |
Vai |
2016 |
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers |
Articolo in rivista |
Vai |
2016 |
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis |
Articolo in rivista |
Vai |
2016 |
Targeting dna double strand break repair with hyperthermia and dna-pkcs inhibition to enhance the effect of radiation treatment |
Articolo in rivista |
Vai |
2016 |
Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling |
Articolo in rivista |
Vai |
2016 |
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b |
Articolo in rivista |
Vai |
2016 |
p63 role in breast cancer |
Articolo in rivista |
Vai |
2015 |
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer |
Articolo in rivista |
Vai |
2015 |
Targeting cancer stem cells and the tumor microenvironment |
Capitolo o Saggio |
Vai |
2015 |
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance |
Articolo in rivista |
Vai |
2015 |
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging |
Articolo in rivista |
Vai |
2015 |
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy |
Articolo in rivista |
Vai |
2015 |
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology |
Articolo in rivista |
Vai |
2015 |
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells |
Articolo in rivista |
Vai |
2015 |
Normal vs cancer thyroid stem cells: the road to transformation |
Recensione in rivista |
Vai |
2015 |
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. |
Articolo in rivista |
Vai |
2014 |
Colorectal Cancer Stem Cells: From the Crypt to the Clinic |
Articolo in rivista |
Vai |
2014 |
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis |
Articolo in rivista |
Vai |
2014 |
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer |
Articolo in rivista |
Vai |
2014 |
p63 isoforms regulate metabolism of cancer stem cells |
Articolo in rivista |
Vai |
2014 |
Estrogens and stem cells in thyroid cancer |
Articolo in rivista |
Vai |
2014 |
Colorectal cancer defeating? Challenge accepted! |
Recensione in rivista |
Vai |
2014 |
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment |
Articolo in rivista |
Vai |
2014 |
γδ T cells as a potential tool in colon cancer immunotherapy |
Articolo in rivista |
Vai |
2013 |
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy |
Articolo in rivista |
Vai |
2013 |
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. |
Articolo in rivista |
Vai |
2013 |
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. |
Articolo in rivista |
Vai |
2013 |
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules |
Articolo in rivista |
Vai |
2013 |
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 |
Articolo in rivista |
Vai |
2013 |
Tumor and its microenvironment: a synergistic interplay. |
Recensione in rivista |
Vai |
2013 |
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vc9Vd2 T Cell-Mediated Cytotoxicity |
Articolo in rivista |
Vai |
2013 |
Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes |
Articolo in rivista |
Vai |
2012 |
INTRODUCING NON-ADHERENT
PROGENITORS FROM ADIPOSE-DERIVED
STEM CELLS (NAPADSCS): PROOF OF
STEMNESS AND POSSIBLE FUTURE
APPLICATIONS IN REGENERATIVE SURGERY |
Abstract in rivista |
Vai |
2012 |
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas |
Articolo in rivista |
Vai |
2012 |
CD133 as a target for colon cancer. |
Articolo in rivista |
Vai |
2012 |
Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells. |
Articolo in rivista |
Vai |
2012 |
ADHESION AND OSTEOGENIC DIFFERENTIATION OF NON-ADHERENT PROGENITORS FROM ADIPOSE-DERIVED STEM CELLS (napASCs) OVER INTEGRA DERMAL REGENERATION TEMPLATE |
Abstract in rivista |
Vai |
2012 |
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. |
Articolo in rivista |
Vai |
2011 |
DOWN REGULATION OF LYMPHOCYTES APOPTOSIS IN GIRLS WITH PRECOCIOUS PUBERTY |
Poster pubblicato in rivista |
Vai |
2011 |
Colorectal cancer stem cells and cell death |
Review essay (rassegna critica) |
Vai |
2011 |
Immunotherapy targeting colon cancer stem cells |
Recensione in rivista |
Vai |
2011 |
Prevention of Chemotherapy-Induced Anemia and
Thrombocytopenia by Constant Administration of Stem Cell Factor |
Articolo in rivista |
Vai |
2011 |
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown |
Recensione in rivista |
Vai |
2011 |
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. |
Articolo in rivista |
Vai |
2011 |
Differentiation, phenotype, and function of
interleukin-17-producing human V{gamma}9V{delta}2 T cells |
Articolo in rivista |
Vai |
2010 |
V{gamma}9V{delta}2 T Lymphocytes Efficiently
Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and
Imatinib-Resistant Chronic Myelogenous Leukemia Cells. |
Articolo in rivista |
Vai |
2010 |
Tumour vascularization via endothelial differentiation of glioblastoma stem-like
cells |
Articolo in rivista |
Vai |
2010 |
Survivin is regulated by interleukin-4 in colon cancer stem cells |
Articolo in rivista |
Vai |
2010 |
In vivo manipulation of Vgamma9Vdelta2 T cells with
zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast
cancer patients. |
Articolo in rivista |
Vai |
2010 |
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. |
Articolo in rivista |
Vai |
2010 |
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. |
Articolo in rivista |
Vai |
2010 |
Evidences of cervical cancer stem cells derived from established cell lines. |
Articolo in rivista |
Vai |
2010 |
Colon cancer stem cells: promise of targeted therapy. |
Articolo in rivista |
Vai |
2010 |
Tumorigenic and metastatic activity of human thyroid cancer stem cells |
Articolo in rivista |
Vai |
2009 |
Role of interleukin-4 on colon cancer stem cell survival |
Proceedings |
Vai |
2009 |
Therapeutic implications of Cancer Initiating Cells. |
Articolo in rivista |
Vai |
2009 |
P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral
Immunotherapy of Multiple Myeloma |
Articolo in rivista |
Vai |
2009 |
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy |
Articolo in rivista |
Vai |
2009 |
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes |
Articolo in rivista |
Vai |
2008 |
Crucial role of interleukin-4 in the survival of colon cancer stem cells |
Articolo in rivista |
Vai |
2008 |
Isolation and culture of colon cancer stem cells. |
Articolo in rivista |
Vai |
2008 |
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. |
Articolo in rivista |
Vai |
2008 |
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. |
Articolo in rivista |
Vai |
2008 |
Galectin-3 immunodetection for improving the performance of conventional thyroid cytology: preliminay results |
Proceedings |
Vai |
2008 |
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme |
Articolo in rivista |
Vai |
2008 |
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 |
Articolo in rivista |
Vai |
2008 |
IL-4-mediated drug resistance in colon cancer stem cells |
Articolo in rivista |
Vai |
2007 |
ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREAMENT OF CANCER |
Brevetto |
Vai |
2007 |
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 |
Articolo in rivista |
Vai |
2007 |
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells |
Articolo in rivista |
Vai |
2007 |
Role of Th cytokines in thyroid autoimmunity |
Articolo in rivista |
Vai |
2007 |
Identification and expansion of human colon-cancer-initiating cells. |
Articolo in rivista |
Vai |
2006 |
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis |
Articolo in rivista |
Vai |
2006 |
Thyroid stem cells: phenotypic properties, differentiation, potential and regulation by bone morphogenetic proteins |
Proceedings |
Vai |
2006 |
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. |
Proceedings |
Vai |
2006 |
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells |
Articolo in rivista |
Vai |
2006 |
Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. |
Articolo in rivista |
Vai |
2006 |
Involvement of MUC1 oncoprotein in thyroid cancer resistance to chemoterapeutic drugs |
Proceedings |
Vai |
2006 |
Optimisation of cancer therapy by sensitization of cancer stem cells within tumorsto death indicing regimens |
Proceedings |
Vai |
2006 |
Sensitizing cells for apoptosis by selectively blocking cytokines. |
Brevetto |
Vai |
2006 |
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. |
Proceedings |
Vai |
2005 |
OSSERVAZIONi A PROPOSITO DI UN CASO DI CISTI GIGANTE DELLA MILZA |
Traduzione in rivista |
Vai |
2005 |
ROLE OF IL-4 AND IL-10 CYTOKYNES IN THE PATHOGENIC MECHANISM OF THYROID CANCER |
Capitolo o Saggio |
Vai |
2005 |
PED/PEA-15 mediates AKT dependent chemoresistance in human breast cancer cells |
Proceedings |
Vai |
2005 |
Il follow-up della tiroidectomia totale dei carcinomi differenziati della tiroide |
Proceedings |
Vai |
2005 |
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells |
Articolo in rivista |
Vai |
2004 |
Cosa c'è di nuovo nel trattamento del carcinoma differenziato della tiroide |
Proceedings |
Vai |
2004 |
CD95 DISC formation and internalizzation occur in lipid rafts of typeI and typeII cells |
Articolo in rivista |
Vai |
2004 |
METHOD FOR THE PURIFICATION AND AMPLIFICATION OF TUMORAL STEM CELLS |
Brevetto |
Vai |
2004 |
SENSITIZING CELLS FOR APOPTOSIS BY SELECTIVELY BLOCKING CYTOKINES |
Brevetto |
Vai |
2004 |
Role of apoptosis in autoimmunity |
Articolo in rivista |
Vai |
2004 |
Metodo per la purificazione e l’ampliamento di cellule staminali tumorali |
Brevetto |
Vai |
2004 |
Th2 cytokines induce chemotherapy resistance in epithelial tumors via PI3K/AKT pathway |
Proceedings |
Vai |
2003 |
Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production of
Interleukin-4 and Interleukin-10 |
Articolo in rivista |
Vai |
2003 |
Islet Beta-Cell Apoptosis Triggered in Vivo by Interleukin-1
Is Not Related to the Inducible Nitric Oxide Synthase
Pathway: Evidence for Mitochondrial Function
Impairment and Lipoperoxidation |
Articolo in rivista |
Vai |
2002 |
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells |
Articolo in rivista |
Vai |
2000 |
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease |
Articolo in rivista |
Vai |
1999 |
Defective apoptosis as potential mechanism in the tumorogenesis of myelolipoma |
Articolo in rivista |
Vai |